A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Clinical trial NCT00197210 · COMPLETED

Trial details

NCT number: NCT00197210
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2003-12-01
Primary completion: 2007-07-01
Enrollment: 10708

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.